Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 13, 2018
Total Value: $992M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma | 2,166,832 | $154M | 15.5% | $26.35 | — | ADR | 04351P101 |
| CRNX | Crinetics Pharmaceuticals Inc | 3,792,169 | $109M | 11.0% | $29.69 | 0.0% | Common | 22663K107 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 2,049,545 | $76.96M | 7.8% | $36.97 | — | Common | G11196105 |
| CDXS | Codexis, Inc. | 2,749,343 | $47.15M | 4.8% | $3.85 | +319.0% | Common | 192005106 |
| SVA | Sinovac Biotech Ltd | 5,900,000 | $44.96M | 4.5% | $7.22 | 0.0% | SHS | P8696W104 |
| ARWR | Arrowhead Pharmaceuticals In | 2,328,475 | $44.64M | 4.5% | $8.05 | +104.0% | Common | 04280A100 |
| — | Amyris, Inc. | 5,575,118 | $44.27M | 4.5% | $5.54 | — | Common | 03236M200 |
| — | Menlo Therapeutics | 4,011,236 | $39.51M | 4.0% | $37.58 | — | Common | 586858102 |
| — | Kadmon Holdings (KDMN) | 10,454,545 | $34.92M | 3.5% | $5.56 | — | Common | 48283N106 |
| — | Tricida, Inc. | 991,711 | $30.3M | 3.1% | $29.90 | — | Common | 89610F101 |
| KALV | KalVista Pharmaceuticals, Inc. | 1,359,149 | $30.05M | 3.0% | $12.10 | +11.7% | Common | 483497103 |
| — | Homology Medicines, Inc. | 1,159,742 | $26.51M | 2.7% | $19.00 | — | Common | 438083107 |
| — | MEI Pharma Inc (NAS) | 5,778,106 | $24.9M | 2.5% | $3.94 | — | Common | 55279B202 |
| APLS | Apellis Pharmaceuticals, Inc. | 1,354,554 | $24.08M | 2.4% | $14.72 | +25.6% | Common | 03753U106 |
| ACRS | Aclaris Therapeutics | 1,647,214 | $23.92M | 2.4% | $19.11 | -10.3% | Common | 00461U105 |
| — | Eiger BioPharmaceuticals | 1,791,257 | $21.5M | 2.2% | $16.42 | — | Common | 28249U105 |
| — | Verona Pharma Plc | 1,492,951 | $18.68M | 1.9% | $13.61 | — | ADS | 925050106 |
| XENE | Xenon Pharmaceuticals Inc | 1,405,476 | $18.55M | 1.9% | $11.59 | 0.0% | Common | 98420N105 |
| — | Nabriva Therapeutics Plc | 6,619,190 | $17.87M | 1.8% | $6.08 | — | SHS | G63637105 |
| — | Acer Therapeutics Inc | 565,579 | $17.44M | 1.8% | $30.84 | — | Common | 00444P108 |
| — | Obseva SA | 937,147 | $16.9M | 1.7% | $15.18 | — | Common | H5861P103 |
| — | Selecta Biosciences, Inc. | 761,253 | $11.84M | 1.2% | $19.86 | — | Common | 816212104 |
| — | Galmed Pharmaceuticals Ltd | 851,492 | $11.56M | 1.2% | $12.02 | — | SHS | M47238106 |
| — | Kala Pharmaceuticals, Inc. | 1,043,020 | $10.29M | 1.0% | $22.84 | — | Common | 483119103 |
| — | Cymabay Therapeutics inc | 906,000 | $10.04M | 1.0% | $13.04 | — | Common | 23257D103 |
| — | Zymeworks Inc | 620,134 | $9.736M | 1.0% | $14.78 | — | Common | 98985W102 |
| — | Soleno Therapeutics, Inc. | 4,359,683 | $9.417M | 0.9% | $1.84 | — | Common | 834203200 |
| — | Deciphera Pharmaceuticals In | 212,648 | $8.234M | 0.8% | $39.35 | — | Common | 24344T101 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,213,290 | $8.056M | 0.8% | $5.62 | -0.2% | Common | 05156V102 |
| — | Kiniksa Pharmaceuticals-A | 264,878 | $6.754M | 0.7% | $19.77 | — | Common | G5269C101 |
| — | Genocea Biosciences Inc(NMS) | 8,180,000 | $6.378M | 0.6% | $1.05 | — | Common | 372427104 |
| — | Zogenix, Inc. | 105,000 | $5.208M | 0.5% | $40.05 | — | Common | 98978L204 |
| ARVN | Arvinas Holding Co LLC | 300,000 | $5.061M | 0.5% | $16.46 | 0.0% | Common | 04335A105 |
| ZLAB | Zai Lab LTD | 231,010 | $4.5M | 0.5% | $27.00 | — | ADR | 98887Q104 |
| — | Strongbridge Biopharma plc | 918,132 | $4.453M | 0.4% | $2.40 | — | SHS USD | G85347105 |
| — | Sierra Oncology, Inc | 2,438,270 | $4.145M | 0.4% | $1.55 | — | Common | 82640U107 |
| — | Trevena, Inc. | 1,728,000 | $3.663M | 0.4% | $7.67 | — | Common | 89532E109 |
| — | BioPharmX Corporation | 16,128,515 | $3.064M | 0.3% | $0.36 | — | Common | 09072X101 |
| — | Foamix Pharmaceuticals Ltd. | 427,500 | $2.45M | 0.2% | $9.26 | — | SHS | M46135105 |
| — | Akari Therapeutics Plc | 345,850 | $885K | 0.1% | $14.00 | — | ADR | 00972G108 |
| — | Agile Therapeutics, Inc. | 1,513,975 | $555K | 0.1% | $6.21 | — | Common | 00847L100 |
| — | Sunesis Pharmaceuticals, Inc. | 195,474 | $391K | 0.0% | $3.62 | — | Common Par | 867328700 |
| — | GTX Inc | 105,043 | $165K | 0.0% | $1.57 | — | Common | 40052B207 |
| — | Soleno Therapeutics, Inc. | 188,772 | $23,000 | 0.0% | $0.14 | — | Warrant | 834203135 |